Business
Alzheimer’s drug aducanumab faces major setback as US authorities consider whether to approve it – ABC News
A drug company is seeking to get an experimental Alzheimer’s drug approved by the FDA. If they succeed it would be a major breakthrough. But just how convincing…
For almost two decades, the field of Alzheimer’s research has been dogged by treatment failures, leaving patients and their families desperate for hope.
But the makers of a new experimental drug, currently under consideration for regulatory approval by the US Food and Drug Administration (FDA), want to change that.
If Aducanumab, developed by pharmaceutical company Biogen, is approved by the FDA, it would be the first Alzheimer’s drug to be greenlit in 20 years.
Last week, Biogen’s stock price soared…
-
Noosa News18 hours agoHockey coach in Arana Hills charged with grooming and sexual offences against teenage girls
-
General18 hours agoWoman killed and man injured in shark attack on NSW Mid North Coast
-
Noosa News19 hours agoDepartment of Transport and Main Roads orders shutdown of North Ipswich Free Shop
-
Noosa News21 hours agoFlawed government agreement opened door for unlawful site access